Welcome to our dedicated page for Volato Group news (Ticker: SOAR), a resource for investors and traders seeking the latest updates and insights on Volato Group stock.
Volato Group, Inc. reports company developments tied to its private aviation services business, including operating and financial results, material agreements, shareholder voting matters and governance updates. News about SOAR also covers capital-structure disclosures involving its public securities, including Class A common stock and warrant-related security matters.
Recurring Volato news themes reflect its role as an aviation technology and private aviation issuer, with updates centered on corporate agreements, public-company governance, security-structure activity and disclosures related to business operations.
Flyte, a subsidiary of Catheter Precision (NYSE American: VTAK), reported preliminary record monthly revenue of approximately $640,000 for July 2026, a 102% sequential increase over June, marking the strongest operating month in Flyte’s history as demand rises on its private aviation platform.
Since relaunching its direct-to-consumer platform, Flyte has added 2,700+ new users, supported by strategic partnerships, digital marketing, and influencer campaigns. In 2026 it expanded partnerships with Blade, Vaunt, Volato AI (NYSE American: SOAR), GSE Worldwide & Emiliano Grillo, LifeVac, and LDV at The Maidstone. Catheter Precision emphasized that June and July 2026 revenue figures are preliminary, unaudited estimates and remain subject to change.
Catheter Precision (NYSE American: VTAK), through its subsidiary Flyte, announced that Flyte has become the inaugural enterprise customer of Volato AI (NYSE American: SOAR), an aviation-focused enterprise artificial intelligence platform. The deployment is intended to support Flyte’s strategy of building a scalable regional private aviation platform using advanced technology and intelligent automation.
According to Catheter Precision, Volato AI is expected to assist Flyte across multiple operational workflows, including customer communications, charter sales support, flight quoting, crew coordination, maintenance scheduling, dispatch support, compliance assistance, document management, operational scheduling, and broader administrative workflow automation. Flyte expects AI to enhance customer responsiveness, automate repetitive tasks, increase employee productivity, and improve operating leverage as short-haul private aviation activity grows.
Volato Group (NYSE American: SOAR) announced the commercial launch of Volato AI, a purpose-built enterprise AI platform for business aviation, and its first enterprise deployment with Flyte, a regional air mobility company owned by Catheter Precision (NYSE American: VTAK). The aviation-specific AI agents are designed to increase employee productivity, improve customer responsiveness, reduce administrative workload, and help operators scale Part 135 charter operations without proportional overhead growth.
The initial Flyte deployment will cover workflows such as customer communications, charter sales support, flight quoting, crew coordination, maintenance scheduling, dispatch support, compliance assistance, document management, and administrative automation. Volato emphasized that its pending AI infrastructure business combination remains the company’s primary strategic focus and is still subject to due diligence, definitive agreements, and regulatory and exchange requirements.
Volato Group (NYSE American: SOAR) announced that its Vaunt platform has completed its first international member flight, marking Vaunt’s expansion beyond the United States. The inaugural flight on July 12, 2026 transported Vaunt members from Florida to The Bahamas via a participating air carrier, demonstrating Vaunt’s ability to support qualifying international itineraries.
According to Volato, this milestone broadens potential experiences for members and monetization opportunities for operators, and builds on earlier reported commercial traction of approximately $4.7 million in annual recurring revenue, record quarterly cash sales, and more than 2,700 paid members as of June 30, 2026. Future international opportunities will depend on operator schedules, aircraft availability, border requirements, and regulatory approvals.
Volato Group (NYSE American: SOAR) issued preliminary Q2 2026 results showing a stronger balance sheet and rapid Vaunt growth. All convertible notes were eliminated, total liabilities (ex‑deferred revenue) fell about 75% year-over-year to $5 million, and cash reached roughly $8.4 million.
Vaunt recorded about $2.2 million in cash sales, up 56% sequentially and 199% year-over-year, with projected ARR of $4.7 million and paid membership up 71% year-over-year. Volato also advanced its Parslee AI workflow platform and continues to evaluate a potential strategic merger targeted for Q3 2026.
Volato (NYSE American: SOAR) closed a $2.2 million PIPE financing priced at $0.34 per share, issuing 6.5 million common shares. Proceeds are intended to strengthen the balance sheet and support its AI-focused aviation strategy and software-enabled operating platforms.
Strategic investors were led by Catheter Precision, parent of Flyte. The deal builds on Volato’s strategic relationship with Flyte and supports development of its AI assets, including Parslee and Volato AI, while the company evaluates potential acquisitions, mergers, and strategic combinations.
Volato (NYSE American: SOAR) is evaluating multiple unsolicited, non-binding LOIs for potential strategic transactions in AI infrastructure, data infrastructure, compute, and power generation. The company recently closed a $2.2 million strategic investment.
Vaunt’s annual recurring revenue reached approximately $4.0 million as of May 2026, up about 221% year-over-year and accelerating from $3.6 million ARR at April 30, 2026.
Volato Group (NYSE American: SOAR) signed a definitive agreement for a $2.2 million strategic investment in restricted common stock, led by Catheter Precision and other institutional investors. The capital is intended to strengthen the balance sheet and support a shift toward AI infrastructure and technology transactions.
The company terminated its prior M2i Global deal and is now evaluating non-binding AI-related letters of intent, while leveraging its existing AI software platform Parslee and the Volato AI initiative. Closing remains subject to NYSE American listing approval and other customary conditions.
Volato Group (NYSE American: SOAR) announced that NYSE Regulation has accepted its plan to regain compliance with NYSE American continued listing standards. The decision allows Volato’s Class A common stock to keep trading while it executes initiatives to improve stockholders’ equity, financial performance, and strategic transformation.
The company has until December 17, 2026 to regain compliance, with progress monitored by NYSE Regulation. Failure to comply or show sufficient progress could lead to delisting proceedings.
BCII Enterprises (OTC:BCII), technology partner to Volato Group (NYSE American: SOAR), announced Aurica Tokenization as the first licensed customer of its Coupon Token platform for 60 million tokens.
BCII will receive 0.6 percentage points of a 6% trading tax on transactions, creating a recurring revenue stream tied to platform activity. Aurica will launch a 1:1 physically backed gold Aurica Token paired with a fixed, consumption-based discount coupon offering a 5% discount to gold spot, with an 11‑month token life and 10‑month trading window. The parties are targeting a fourth quarter 2026 commercial launch on a Horizon-powered Ethereum Layer‑2 blockchain, supported by a previously obtained favorable accounting opinion for the Coupon Token program.